Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	549.71	284.12	422.64	352.98	147.46	121.79
Trading Asset Securities	-	-	-	-	200.31	341.06
Cash & Short-Term Investments	549.71	284.12	422.64	352.98	347.78	462.85
Cash Growth	44.94%	-32.77%	19.73%	1.50%	-24.86%	644.14%
Accounts Receivable	417.84	416.78	374.28	318.43	326.39	222.79
Other Receivables	18.87	11.89	16.48	10.47	13.56	12.03
Receivables	436.71	428.67	390.76	328.89	339.95	234.82
Inventory	648.49	532.13	406.92	226.46	135.51	106.21
Other Current Assets	172.23	219.16	131.43	141.7	39.81	48.62
Total Current Assets	1,807	1,464	1,352	1,050	863.06	852.5
Property, Plant & Equipment	3,851	3,844	3,213	2,620	951.83	528.43
Long-Term Investments	123.23	124.45	123.45	112.4	40	7
Other Intangible Assets	147.16	150.04	137.73	86.28	73.17	43.98
Long-Term Deferred Tax Assets	133.49	145.3	86.54	49.39	40.48	14.39
Long-Term Deferred Charges	16.48	13.64	5.79	-	-	-
Other Long-Term Assets	53.07	33.51	71.17	51.9	58.54	27.8
Total Assets	6,132	5,775	4,989	3,970	2,027	1,474

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	557.59	712.68	564.03	589.01	221.64	99.87
Accrued Expenses	34.67	52.07	44	36.87	35.06	17.95
Short-Term Debt	263.06	123.38	681.98	915.12	79.23	18.5
Current Portion of Long-Term Debt	466.56	363.03	225.75	26.6	-	-
Current Income Taxes Payable	10.88	3.58	4.92	25.5	5.32	6.67
Current Unearned Revenue	27.16	17	17.4	12.77	19.61	17.57
Other Current Liabilities	122.55	67.59	65.45	70.61	27.9	22.34
Total Current Liabilities	1,482	1,339	1,604	1,676	388.75	182.89
Long-Term Debt	1,772	1,572	637.81	304.93	-	-
Long-Term Unearned Revenue	88.88	94.75	87.62	91.53	102.63	86.23
Long-Term Deferred Tax Liabilities	109.87	136.32	102.07	71.64	54.05	21.85
Total Liabilities	3,453	3,143	2,431	2,145	545.44	290.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	250.12	250.12	249.72	157.54	108.4	108.4
Additional Paid-In Capital	1,218	1,218	1,209	603.46	624.47	588.04
Retained Earnings	1,289	1,228	1,158	1,110	758.99	498.69
Treasury Stock	-50.01	-50.01	-53.61	-45.24	-12	-12
Comprehensive Income & Other	-0.82	0.43	0.96	0.72	0.64	-
Total Common Equity	2,706	2,647	2,565	1,827	1,480	1,183
Minority Interest	-28.01	-14.82	-6.27	-1.31	1.15	-
Shareholders' Equity	2,678	2,632	2,558	1,826	1,482	1,183
Total Liabilities & Equity	6,132	5,775	4,989	3,970	2,027	1,474

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,502	2,059	1,546	1,247	79.23	18.5
Net Cash (Debt)	-1,952	-1,775	-1,123	-893.67	268.55	444.35
Net Cash Growth	-	-	-	-	-39.56%	6128.38%
Net Cash Per Share	-7.78	-7.10	-4.86	-3.90	1.18	2.14
Filing Date Shares Outstanding	256.66	248.79	235.72	227.71	227.91	227.91
Total Common Shares Outstanding	256.66	248.79	235.72	227.71	227.91	227.91
Working Capital	324.68	124.76	-251.78	-626.43	474.3	669.61
Book Value Per Share	10.54	10.64	10.88	8.02	6.50	5.19
Tangible Book Value	2,559	2,497	2,427	1,741	1,407	1,139
Tangible Book Value Per Share	9.97	10.04	10.30	7.64	6.17	5.00
Buildings	-	862.98	755.99	462.42	290.67	200.66
Machinery	-	2,449	1,307	952.21	703.78	439.11
Construction In Progress	-	1,192	1,606	1,529	188.91	65.33

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error